Sebia signs agreement with Janssen Biotech to develop a multiple myeloma IVD test

Sebia signs agreement with Janssen Biotech to develop a multiple myeloma IVD test

Paris, France, January 30, 2017 – Sebia, a world leader in multiple myeloma diagnostics and monitoring, announces today that it…